Clinical Trial Update: Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 [Phase 3]

View source ↗

Summary

Phase 3 trial in antiretroviral-naive patients infected with CCR5-tropic HIV-1 comparing maraviroc-containing therapy to emtricitabine/tenofovir disoproxil fuma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• PREZISTA (darunavir)
• Selzentry (Maraviroc)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV-1 | Phase 3 | Status: TERMINATED | Results posted: 2016-01-14